Archives

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Shields Health Solutions Partners with Major Academic Medical Center to Expand Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions Partners with Major Academic Medical Center to Expand Specialty Pharmacy Services

STOUGHTON, Mass. (May 13, 2025)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country announced it has partnered with Duke Health, a leading academic health system in North…

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions 70 70 Shields Health Solutions

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions

Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening 70 70 Shields Health Solutions

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening

Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2024 marked its 20th anniversary — and we couldn’t be…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

This poster evaluates the clinical and quality outcomes of a bleeding disorder program at a health system HSSP.

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation 216 115 Shields Health Solutions

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation

This poster aims to establish goals for a dashboard displaying medication adherence by disease state and PDC thresholds through a comprehensive literature review, validating the existing targets.

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients

This poster explores the impact of a Health System Specialty Pharmacy care model paired with a pharmacist-led CDTM program on CF patient outcomes.

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients 204 115 Shields Health Solutions

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.